New Insights on Alzheimer’s and What it means for Personalized Medicine
A rapidly aging nation, the U.S. has 60
SYNTap™ Test
The SYNTap Biomarker Test helps physicians diagnose synucleinopathies such as:
Parkinson’s Disease
How the SYNTap Test helps improve diagnostic accuracy for various types of Parkinson's.
Lewy Body Dementia
How the SYNTap Test can improve the diagnostic challenges of Lewy Body Dementia.
AD with Lewy Bodies
How the SYNTap Test helps differentiate the Alzheimer's variant: AD with Lewy Bodies.
Multiple System Atrophy
How the SYNTap Test helps physicians differentiate MSA from Parkinson's disease.
MCI with Lewy Bodies
How the SYNTap Test helps detect Minimal Cognitive Impairment with Lewy Bodies early.
Download Spec. Sheet
Details on the SYNTap Biomarker Test performance characteristics.
Explore Our Science
A pioneer of Prion Detection Science™️, Amprion innovates biomarker testing to accurately detect misfolded proteins associated with brain diseases.
After decades of research, Amprion is thrilled to rollout its impactful discoveries from the lab to the world.
Amprion in the News
Amprion Awarded CAP Accreditation
Amprion Clinical Laboratory Receives Accreditation From College Of
Launch of SYNTap™ Test
SYNTap™ Test Announcement Breakthrough biomarker test aids physicians
